BioCentury
ARTICLE | Financial News

Immunovaccine completes follow-on

September 1, 2014 7:00 AM UTC

Immunovaccine Inc. (TSX-V:IMV), Halifax, Nova Scotia Business: Cancer, Infectious Date completed: 2014-08-26 Type: Follow-on Raised: C$8.7 million ($8 million) Units: 9.2 million Price: C$0.95 (unit) ...